Creating a 3D printed radiation system for small animals
Official title: Development of a 3D printed small animal intensity modulated radiation system
Funded at University of California Los Angeles · NIH-11283737 · Data updated 2026-11-12
This study is working on a new type of radiation therapy for small animals like mice, which are often used in research, to make treatments more precise and effective, helping scientists get better results that could apply to humans.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project start | May 1, 2024 |
| Project end | August 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $190,232 |
| NIH project number | 7R01CA282496-02 |
| Project ID | NIH-11283737 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research include those involved in preclinical studies or those interested in the development of more effective cancer treatments.
✕Less likely to help
Patients who are not involved in preclinical research or who do not have conditions requiring radiation therapy may not benefit from this research.
What this research studies
This research focuses on developing a new radiation therapy system specifically designed for small animal models, such as mice, which are commonly used in biomedical research. The goal is to enhance the accuracy and effectiveness of radiation treatments in these models by using advanced techniques similar to those used in human clinical settings. By implementing intensity modulated radiation therapy (IMRT), the researchers aim to improve the reproducibility of preclinical results, making them more relevant for human applications. This innovative approach seeks to bridge the gap between clinical and preclinical radiation therapy methodologies.
Why it matters
Potential benefit: If successful, this research could lead to more effective preclinical studies that better predict human responses to radiation therapy.
How similar studies have gone: While the approach of using IMRT in clinical settings has shown success, the application of this technology in small animal models is relatively novel and has not been extensively tested.
Where this research is happening
-
University of California Los Angeles
Los Angeles, United States Active
Researchers
- Principal investigator: Wiersma, Rodney — University of California Los Angeles
- Study coordinator: Wiersma, Rodney
Related research
Other NIH-funded projects on the same topics.
-
Understanding how genetic changes in blood cells relate to heart disease in people with HIV
A study will look at how age-related blood cell mutations and large chromosomal changes might contribute to heart disease risk in people living with HIV.
-
Systems genetics of vascular smooth muscle phenotypes in heart disease
Aims to understand how genetic differences influence vascular smooth muscle cells to improve prevention and treatment of coronary artery disease.
-
Motivation for Alcohol Use in Humans and How It Can Be Measured
This grant explores how people are motivated to drink alcohol and tests a safe, controlled way to study that motivation to inform better treatments for alcohol use disorder.
-
Overcoming CAR T cell resistance with tumor-targeted IL-12 to boost anti-tumor immunity
Aims to make CAR T cell therapy work better for solid tumors by using tumor-focused IL-12 to boost the body’s attack on cancer.
-
PediCODE: A Biorepository and Consortium for CoDE - Congenital Diarrhea and Enteropathy
A nationwide effort to collect clinical data and patient-derived samples to uncover the genetic causes of congenital diarrhea and enteropathy and to build a resource that helps researchers study these diseases.
-
Mentor Moms+: a community-led plan to cut alcohol use and HIV risk during pregnancy in South Africa
A community-based program adapts a trusted peer-led model to help pregnant and lactating people reduce alcohol use and HIV risk in South Africa.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.